Oura launches trial on ring data and obesity treatment
Oura said it has launched a clinical trial to study how sleep, heart rate and other metrics collected by its smart ring relate to GLP-1 drug treatment outcomes.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Oura said it has launched a clinical trial to study how sleep, heart rate and other metrics collected by its smart ring relate to GLP-1 drug treatment outcomes.
Oura said it launched a clinical trial examining how sleep, heart rate and other smart-ring measures are associated with outcomes of obesity treatments, including GLP-1 drugs and bariatric surgery.